India's first malaria vaccine could be a turning point in disease fight

With AdFalciVax, India's first indigenous malaria vaccine, the country makes a strong push toward eliminating malaria by 2030

Earlier this week, the Indian Council of Medical Research (ICMR) licensed its multi-stage malaria vaccine AdFalciVax to five companies, marking a milestone in India’s decades-long fight against the disease. This move comes at a time when India is making strides in its efforts to eliminate malaria by 2030.

India’s first indigenous vaccine against the deadliest malaria parasite

The companies — Indian Immunologicals Limited, TechInvention Lifecare Private Limited, Panacea Biotec Limited, Biological E Limited, and Zydus Lifesciences — will now manufacture AdFalciVax, India’s first indigenous multi-stage malaria recombinant vaccine. Developed by the Regional Medical Research Centre (RMRC) in Bhubaneswar under the ICMR, the vaccine can prevent Plasmodium falciparum infections — the deadliest strain of malaria — and minimise community transmission.

 

 

The vaccine targets the parasite before it enters the bloodstream, blocking the transmission stage. According to reports, it is affordable, scalable, and remains effective for over nine months at room temperature.

India’s zero-malaria goal and recent progress

The country aims to achieve zero indigenous malaria cases by 2027 and complete elimination by 2030, under the National Framework for Malaria Elimination (2016–2030) and the National Strategic Plan for Malaria (2023–27).

 

According to the World Malaria Report 2024, India has reduced malaria cases and deaths by more than 80 per cent over the past decade. Cases dropped from 6.4 million in 2017 to around 2 million in 2023, while deaths fell from 11,100 to just 3,500. Additionally, over 122 districts reported zero cases last year.

 

In 2024, India exited the WHO’s High Burden to High Impact (HBHI) category, marking a significant turnaround in malaria control. The Ministry of Health and Family Welfare reported that 122 districts recorded zero malaria cases in 2023.

Persistent hotspots and new outbreaks

Despite strong progress, malaria hotspots remain in states such as Odisha, Chhattisgarh, Jharkhand, and the Northeast — especially in tribal and border areas.

 

“These are regions where healthcare access is limited, malnutrition is common, and cross-border transmission complicates control efforts,” said health experts in reports published by the Asia Pacific Leaders Malaria Alliance (APLMA).

 

According to media reports, recent flooding has also triggered outbreaks in urban centres like Delhi, Noida, and Ghaziabad, prompting intensified anti-mosquito campaigns. Delhi alone reported 264 malaria cases as of September 2025 — the highest in four years.

What AdFalciVax could change

The introduction of AdFalciVax could be a game-changer. By reducing P. falciparum infections and transmission, the vaccine may prevent local flare-ups from escalating into wider outbreaks. Experts believe that combining vaccination with the existing “Test, Treat, Track” strategy could accelerate the elimination timeline.

 

“India has achieved transformational progress in reducing malaria cases and deaths. The addition of an indigenous vaccine adds a critical layer of defence,” said an official statement from the Ministry of Health and Family Welfare.

 

Currently, the vaccine has been licensed for scale-up and manufacturing, with human trials expected to determine its real-world impact. With strong political will and strategic planning, India may soon be free from a disease that once caused millions of cases and thousands of deaths every year.

Understanding malaria and its spread

Malaria is a life-threatening disease caused by parasites transmitted through the bites of infected female Anophelesmosquitoes. It is most common in tropical and subtropical regions but is both preventable and treatable.

 

The disease does not spread directly from person to person, but it can be transmitted through infected blood transfusions, organ transplants, or contaminated needles. Among the parasite species, Plasmodium falciparum is the most dangerous. If left untreated, it can cause severe illness and even death within 24 hours of symptom onset.

 

Malaria symptoms typically appear 10–15 days after being bitten and include fever, headache, and chills.

How to prevent malaria

Malaria can be prevented by avoiding mosquito bites. According to the Health Ministry, travellers visiting high-risk areas should consult doctors about taking preventive medication (chemoprophylaxis).

 

Preventive steps include:

• Using mosquito nets while sleeping
• Applying insect repellents containing DEET, IR3535, or Icaridin
• Avoiding outdoor exposure during dusk and dawn in endemic areas

Since you're already here

…and clearly interested in your health, take a moment to explore our varied range of stories on wellness, medical research, and public health insights.

• Men's grooming essentials  Adult acne, dull skin, hair loss: Skincare tips every man should know
• What a heart doctor won’t eat  10 foods a cardiologist avoids after 20 years treating heart disease
• Early cataracts and screen stress  Cataracts in 30s and 40s? How screen time and stress may be clouding vision
• Eat to prevent cardiac arrest  Heart-smart eating: Diet tips to lower risk of sudden cardiac arrest
• Everyday foods linked to cancer  Doctor warns against these 6 everyday foods that may raise cancer risk
• Fitness trends under the microscope  Are these popular Instagram fitness trends actually helpful or just hype?
• Back pain? Walk it off  Want to avoid chronic back pain? Walk over 100 minutes a day, says study
• Hidden heart hazards at work  Why your office coffee cup and lunch box may raise heart disease risks
• How to be heard at work  Speak up at work: What to do when you're feeling ignored and invisible
• Beyond sobriety: Addiction recovery  Why recovery from addiction needs more than just quitting substances

For more health updates, follow #HealthWithBS 

This content is for informational purposes only and is not a substitute for professional medical advice.